Welcome to the international HTA database

Showing [23537 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2019	NIHR Health Technology Assessment programme	MRI in the diagnosis of fetal developmental brain abnormalities: the MERIDIAN diagnostic accuracy study
2019	Andalusian Health Technology Assessment Area (AETSA)	[Post-introduction observational study of predictive/prognostic tests in breast cancer of the Andalusian Public Health System (SSPA)]
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Pirfenidone in pulmonary fibrosis]
2019	NIHR Health Technology Assessment programme	Intravenous co-amoxiclav to prevent infection after operative vaginal delivery: the ANODE RCT
2019	NIHR Health Services and Delivery Research programme	Improving NHS quality using internet ratings and experiences (INQUIRE)
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Hyaluronic acid dermal fillers in skin repair procedures]
2019	Agency for Healthcare Research and Quality (AHRQ)	Achieving health equity in preventive services
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Alirocumab for patients with hypercholesterolemia]
2019	NIHR Health Technology Assessment programme	Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[PET-CT in patients with head and neck cancer diagnosis]
2019	Agency for Healthcare Research and Quality (AHRQ)	Addressing social isolation to improve the health of older adults: a rapid review
2019	NIHR Health Technology Assessment programme	Anal fistula plug versus surgeon's preference for surgery for trans-sphincteric anal fistula: the FIAT RCT
2019	NIHR Health Services and Delivery Research programme	Evaluation of specialist nursing support for carers of people with dementia
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Relex® SMILE® surgery for refractive errors]
2019	Agency for Healthcare Research and Quality (AHRQ)	Adverse effects of pharmacological treatments of major depression in older adults
2019	NIHR Health Services and Delivery Research programme	Understanding and enhancing how hospital staff learn from and act on patient experience data
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Liraglutide in obese and overweight patients]
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Respiratory polygraphy for obstructive sleep apnea syndrome]
2019	Agency for Healthcare Research and Quality (AHRQ)	Antipsychotics for the prevention and treatment of delirium
2019	NIHR Health Services and Delivery Research programme	A study of sense-making strategies and help-seeking behaviours associated with the use and provision of urgent care services
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Thiazolidinediones for type 2 diabetes mellitus]
2019	NIHR Health Technology Assessment programme	Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study
2019	NIHR Health Technology Assessment programme	Refusal and resistance to care by people living with dementia being cared for within acute hospital wards: an ethnographic study
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Positron-emission tomography for breast cancer]
2019	The Regional Health Technology Assessment Centre (HTA-centrum)	Efficacy of sleep deprivation in patients with depression including bipolar depression
2019	NIHR Health Technology Assessment programme	A school-based intervention ('Girls Active') to increase physical activity levels among 11- to 14-year-old girls: cluster RCT
2019	Penn Medicine Center for Evidence-based Practice (CEP)	The Effect of Patient Communication About Medical Errors on Malpractice Lawsuits
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Intra-articular hyaluronic acid (viscosupplementation) for osteoarthritis]
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Interventions to Reduce the Use of the High Risk Medications in Elderly Patients
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Kinanthropometric nutritional assessment]
2019	The Regional Health Technology Assessment Centre (HTA-centrum)	Gene expression profiles to guide adjuvant chemotherapy in luminal, HER2-negative breast cancer
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Natalizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Guidelines for Supplementary Feedings of Newborn Infants
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[High frequency chest compression vest for ambulatory pulmonary physical therapy in patients with cystic fibrosis]
2019	The Regional Health Technology Assessment Centre (HTA-centrum)	Impact of postmastectomy radiotherapy on complications and results of immediate breast reconstruction
2019	NIHR Health Technology Assessment programme	Developing an intervention around referral and admissions to intensive care: a mixed-methods study
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Bioresorbable stents for the treatment of cardiovascular indications (coronary artery disease). EUnetHTA-Report
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Cerliponase alfa in neuronal ceroid lipofuscinosis type 2]
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Lenvatinib (hepatocellular carcinoma) - Benefit assessment according to §35a Social Code Book V]
2019	The Regional Health Technology Assessment Centre (HTA-centrum)	EEG-based neurofeedback as treatment for post-traumatic stress disorder
2019	NIHR Health Technology Assessment programme	Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Olaparib (Lynparza®) as first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer
2019	The Regional Health Technology Assessment Centre (HTA-centrum)	Trabecular bone pattern assessment in dental radiographs for prediction of bone fracture risk
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Atezolizumab (Tecentriq®) with nab-paclitaxel (Abraxane®) for the treatment of advanced triple-negative breast cancer (aTNBC)
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Prolotherapy in chronic musculoskeletal disorders]
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections. EUnetHTA-Report
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Percutaneous cement discoplasty for the treatment of degenerative scoliosis in the elderly]
2019	NIHR Health Technology Assessment programme	Treatment of first-time traumatic anterior shoulder dislocation UK.TASH-D Study
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Evaluation methods for the benefit assessment of easily accessible, outpatient health centres for vulnerable groups - Target group focus: Homeless and non-insured persons
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Shear-wave elastography for liver fibrosis]
2019	Agency for Healthcare Research and Quality (AHRQ)	Comparative effectiveness of analgesics to reduce acute pain in the prehospital setting
2019	National Institute for Health and Care Excellence (NICE)	UrgoStart for treating diabetic foot ulcers and leg ulcers. NICE medical technologies guidance 42
2019	NIHR Health Services and Delivery Research programme	The changing general practitioner workforce: the development of policies and strategies aimed at retaining experienced GPs and those taking a career break in direct patient care (ReGROUP)
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Robot-assisted surgery in thoracic and visceral indications
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: Alphanate - von Willebrand disease]
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Bendamustine as first line therapy for indolent non-Hodgkin’s lymphoma]
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Darolutamide for the treatment of patients with nonmetastatic castration-resistant prostate cancer (CRPC)
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Erenumab in migraine prevention]
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Annulus Fibrosus Repair after lumbar discectomy
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[4CMenB vaccine for primary vaccination]
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Single/two-step scaffold-based cartilage repair in the knee and ankle joint
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Teriparatide in biphosphonate-resistant osteoporosis and high fracture risk]
2019	Agency for Care Effectiveness (ACE)	Video capsule endoscopy for diagnosing obscure gastrointestinal bleeding
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Radiofrequency denervation for lumbar and cervical facet joint pain – a systematic review
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Immunocyanin in urothelial bladder cancer
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Upper Airway Stimulation for Moderate-to-Severe Sleep Apnea. 1st Update 2019
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Central auditory processing disorder diagnosis]
2019	Agency for Care Effectiveness (ACE)	Ambulatory sleep study for diagnosing obstructive sleep apnoea
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Benefit assessment of biotechnologically produced drugs for the treatment of rheumatoid arthritis]
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Osteochondral allograft transplantation for the knee (or other joints)
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Selexipag in pulmonary hypertension]
2019	NIHR Health Technology Assessment programme	Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Allograft for anterior and posterior cruciate ligament reconstruction
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Holmium laser enucleation in benign prostatic hyperplasia]
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Human dermal allograft for massive rotator cuff tears
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[No-scalpel versus conventional vasectomy]
2019	NIHR Health Services and Delivery Research programme	PRESENT: Patient Reported Experience Survey Engineering of Natural Text: developing practical automated analysis and dashboard representations of cancer survey freetext answers
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	177Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate
2019	National Committee for Technology Incorporation (CONITEC)	[Diagnostic tests for thrombophilia in pregnancy]
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Quantitative electroencephalography]
2019	Haute Autorite de sante (HAS)	[Lymphoseek (tilmanocept), radiopharmaceutical for diagnostic use]
2019	NIHR Health Technology Assessment programme	Stepped approach to improving sexual function after gynaecological cancer: the SAFFRON feasibility RCT
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Custom-made or customisable 3D printed implants and cutting guides versus non- 3D printed standard implants and cutting guides for improving outcome in patients undergoing knee, maxillofacial, or cranial surgery
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Reiki therapy in anxiety, depression and pain]
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ocriplasmin (vitreomacular traction, including when associated with macular hole) - Benefit assessment according to §35a Social Code Book V (reassessment after expiry of the decision)]
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Brentuximab vedotin (Adcetris®) in combination with chemotherapy for CD30-positive peripheral T-cell lymphoma (PTCLs)
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Hip arthroscopy for painful hip treatment]
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Durvalumab (non-small cell lung cancer) - Benefit assessment according to §35a Social Code Book V]
2019	National Institute for Health and Care Excellence (NICE)	Regorafenib for previously treated advanced hepatocellular carcinoma. NICE technology appraisal guidance 555
2019	NIHR Health Technology Assessment programme	Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCT
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Irreversible electroporation for the treatment of liver and pancreatic cancer
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Prostate rectum spacing in prostate radiation therapy]
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Pembrolizumab (head and neck squamous cell carcinoma) - Benefit assessment according to §35a Social Code Book V]
2019	National Institute for Health and Care Excellence (NICE)	Darvadstrocel for treating complex perianal fistulas in Crohn's disease. NICE technology appraisal guidance 556
2019	NIHR Health Technology Assessment programme	Anaesthetic analgesic ear drops to reduce antibiotic consumption in children with acute otitis media: the CEDAR RCT
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Screening and prevention programmes for children and adolescents from 6 to 14 years. Results from selected countries and recommendations from evidence-based guidelines
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Endovascular thrombectomy in acute ischemic stroke]
2019	National Institute for Health and Care Excellence (NICE)	Bevacizumab with carboplatin, gemcitabine and paclitaxel for treating the first recurrence of platinum-sensitive advanced ovarian cancer (terminated appraisal). NICE technology appraisal guidance 560
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Screening for Diabetes mellitus: guideline recommendations